to save a life with early detection of cervical cancer • • • Pap cytology does not uncover all disease1,2 Normal cytology does not always mean cancer free1,2 99 % of cervical cancer is attributable to hrHPV genotypes3,4 1 sample, 1 test, 3 results for confident risk stratification: The cobas® HPV Test detects 14 high-risk genotypes with the ability to provide specific genotype results for HPV16 and HPV18. For more information kindly refer to the following websites www.hpv16and18.com; www.sasog.co.za Call Centre: 0861 cobas HPV (262274) References: 1. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97:675683. 2. Andrae B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100:622-629. 3. Naucler P, Ryd W, Törnberg S, et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst. 2009;101:88-99. 4. Wallboomers JMM, Jacobs MV, Manos MM, et al. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19. Roche Diagnostics (Pty) Ltd, PO BOX 1927, Randburg, 2125. Tel: 011 5044600. www.roche.co.za HPV advert.indd 1 A0005. 2013/03/05 9:08 AM